NL8301722A - Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. - Google Patents

Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. Download PDF

Info

Publication number
NL8301722A
NL8301722A NL8301722A NL8301722A NL8301722A NL 8301722 A NL8301722 A NL 8301722A NL 8301722 A NL8301722 A NL 8301722A NL 8301722 A NL8301722 A NL 8301722A NL 8301722 A NL8301722 A NL 8301722A
Authority
NL
Netherlands
Prior art keywords
weight
cimetidine
sodium salicylate
indomethacin
ulcer
Prior art date
Application number
NL8301722A
Other languages
English (en)
Dutch (nl)
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU153682A external-priority patent/HU188167B/hu
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NL8301722A publication Critical patent/NL8301722A/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL8301722A 1982-05-14 1983-05-13 Farmaceutische samenstellingen, die meer actieve ingredienten bevatten. NL8301722A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU153582 1982-05-14
HU153582 1982-05-14
HU153682 1982-05-14
HU153682A HU188167B (en) 1982-05-14 1982-05-14 Process for producing new pharmaceutical compositions against ulcer

Publications (1)

Publication Number Publication Date
NL8301722A true NL8301722A (nl) 1983-12-01

Family

ID=26317386

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8301722A NL8301722A (nl) 1982-05-14 1983-05-13 Farmaceutische samenstellingen, die meer actieve ingredienten bevatten.

Country Status (13)

Country Link
AR (1) AR230570A1 (xx)
AU (1) AU1459183A (xx)
BE (1) BE896711A (xx)
CA (1) CA1211374A (xx)
CH (1) CH655243A5 (xx)
DD (1) DD209735A5 (xx)
DE (1) DE3317578A1 (xx)
DK (1) DK215883D0 (xx)
FI (1) FI831687L (xx)
FR (1) FR2527078B1 (xx)
GB (1) GB2120938B (xx)
NL (1) NL8301722A (xx)
SE (1) SE8302689L (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189788B1 (de) * 1985-01-23 1989-09-13 ASTA Pharma Aktiengesellschaft Synergistische Kombination von Flupirtin und nicht-steroidalen Antiphlogistika
US5260333A (en) * 1986-08-08 1993-11-09 Bristol Myers Squibb Company Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
WO1992015332A1 (en) * 1991-03-04 1992-09-17 Warner-Lambert Company Novel salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
HU213101B (en) * 1992-12-29 1997-02-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170329B (xx) * 1974-12-12 1977-05-28
US4198402A (en) * 1975-12-17 1980-04-15 Richter Gedeon Vegyeszeti Gyar Rt. Antiphlogistic composition of phenylbutozone and alkali salicylate and method of treatment
US4200631A (en) * 1975-12-17 1980-04-29 Richter Gedeon Vegyeszeti Gyar Rt. Treating mammalian subject sensitive to indomethacin ulcerogenisis
NZ196349A (en) * 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents

Also Published As

Publication number Publication date
FR2527078A1 (fr) 1983-11-25
CH655243A5 (de) 1986-04-15
SE8302689D0 (sv) 1983-05-10
DK215883D0 (da) 1983-05-13
DE3317578A1 (de) 1983-12-01
FI831687L (fi) 1983-11-15
FI831687A0 (fi) 1983-05-13
GB2120938B (en) 1985-09-18
FR2527078B1 (fr) 1987-06-12
BE896711A (fr) 1983-09-01
GB2120938A (en) 1983-12-14
DD209735A5 (de) 1984-05-23
GB8313269D0 (en) 1983-06-22
AR230570A1 (es) 1984-05-31
SE8302689L (sv) 1983-11-15
AU1459183A (en) 1983-11-17
CA1211374A (en) 1986-09-16

Similar Documents

Publication Publication Date Title
EP1035854A1 (en) Use of alpha-glucosidase inhibitors for treating high-risk impaired glucose tolerance
KR20010013618A (ko) 치료학적 활성 조성물
KR101516677B1 (ko) 지방성 간 질환의 치료용 의약 조성물
HUT71476A (en) Pharmaceutical compositions for inhibition of ldl oxidation and atherosclerosis containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
HUT71327A (en) Pharmaceutical compositions for inhibition of autoimmune diseases containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation
NL8301722A (nl) Farmaceutische samenstellingen, die meer actieve ingredienten bevatten.
KR100625399B1 (ko) 리파아제 억제제 및 글루코마난을 포함하는 약학 조성물
KR100515918B1 (ko) 면역 조절용 약학 조성물
Petersen et al. Medication-induced oesophageal disorders
WO1997045141A1 (fr) Remede pour maladies auto-immunes
EP1030664A1 (en) Pharmaceutical compositions containing zafirlukast
HU200684B (en) Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and active on gastrointestinal tract
KR0175345B1 (ko) 장점막 장애 예방 및 치료제
EP0679394B1 (en) Menatetronome derivative as antiarteriosclerotic agent
JP4203170B2 (ja) 医薬組成物
KR100817932B1 (ko) 베르바민을 유효성분으로 포함하는 혈관 재협착 예방제
JP4931598B2 (ja) 腸ポリープ抑制剤
US3080286A (en) Constipation correctives
JP4426654B2 (ja) 免疫調節用医薬組成物
AU2003243986A1 (en) A pharmaceutical composition for preventative and/or therapeutic treatment of constipation and symptom resulting in constipation
JP2004168766A (ja) α−グルコシダーゼ阻害剤
JP2898930B2 (ja) 消化器症状改善剤
JP2006327996A (ja) 血糖の上昇を抑制するための薬剤または機能性食品
IL44996A (en) Pharmaceuticals Containing History 5 - Mercaptopyridoxine for the Treatment of Rheumatoid Arthritis
HU206616B (en) Process for producing pharmaceutical compositions containing pharmaceutically active tetrahydro-naphtalene derivative

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed